Source: Breathe, 14 (3) 216; 10.1183/20734735.020318
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Martyn F. Biddiscombe, Omar S. Usmani. Is there room for further innovation in inhaled therapy for airways disease?. Breathe, 14 (3) 216; 10.1183/20734735.020318

Member's Comments

No comment yet.

Related content which might interest you: Inhaled therapies: can they breathe new life into asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective Source: Eur Respir J 2005; 26: Suppl. 49, 277s Year: 2005 Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment Source: Eur Respir J 2008; 31: 1145-1147 Year: 2008 Mild asthma. Is constant therapy by inhaled steroids necessary? Source: Eur Respir J 2006; 28: Suppl. 50, 500s Year: 2006 What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2011; 37: 1308-1417 Year: 2011 COPD guides and inhaled corticosteroids. Is there an adequate use in primary care? Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Predicting physician decision to prescribe systemic corticosteroids following an exacerbation of airways disease Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD Source: Eur Respir J, 54 (6) 1900521; 10.1183/13993003.00521-2019 Year: 2019 Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma Source: Eur Respir J, 55 (5) 2000954; 10.1183/13993003.00954-2020 Year: 2020 What to use INSTEAD of inhaled corticosteroids in COPD? Source: Eur Respir J 2014; 44: 1391-1393 Year: 2014 What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2012; 39: 1054-1055 Year: 2012 What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2012; 39: 1055-1056 Year: 2012 What the pulmonary specialist should know about the new inhalation therapies Source: Guideline 2011 Year: 2011 Inhaled beta2-agonists in asthma management: an evolving story Source: Breathe 2016; 12: 375-377 Year: 2016 Inhaled formoterol in the treatment of acute asthma exacerbation at emergency room Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004 Therapeutic approaches beyond positive airway pressure and bronchodilators: time for rehabilitation? Source: Sleep and Breathing Conference 2021 Year: 2021 Are inhaled corticosteroids increasing the “load” for some patients with COPD? Source: Eur Respir J, 50 (4) 1701848; 10.1183/13993003.01848-2017 Year: 2017 Treatment options for air pollutant-driven airway disease Source: International Congress 2017 – Effects of air pollution on asthma and COPD Year: 2017